These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2418692)

  • 1. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.
    Churg A
    Am J Surg Pathol; 1985 May; 9(5):360-5. PubMed ID: 2418692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
    al-Saffar N; Hasleton PS
    Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
    Chenard-Neu MP; Bellocq JP; Maier A; Batzenschlager A
    Ann Pathol; 1990; 10(1):20-7. PubMed ID: 2328062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized benign biphasic mesothelioma of the pleura.
    Bürrig KF
    Histopathology; 1987 Sep; 11(9):983-6. PubMed ID: 2444525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
    Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
    Lung; 1995; 173(2):79-87. PubMed ID: 7536281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of vimentin antibodies in the diagnosis of malignant mesothelioma.
    Jasani B; Edwards RE; Thomas ND; Gibbs AR
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(4):441-8. PubMed ID: 3925619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
    Cagle PT; Truong LD; Roggli VL; Greenberg SD
    Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas.
    Khoury N; Raju U; Crissman JD; Zarbo RJ; Greenawald KA
    Hum Pathol; 1990 Aug; 21(8):811-9. PubMed ID: 1696923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.
    Wirth PR; Legier J; Wright GL
    Cancer; 1991 Feb; 67(3):655-62. PubMed ID: 1702354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma.
    Mullink H; Henzen-Logmans SC; Alons-van Kordelaar JJ; Tadema TM; Meijer CJ
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(1):55-65. PubMed ID: 2435052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.
    Holden J; Churg A
    Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive lesions of the pleura. Immunohistochemical characterization.
    Brockmann M; Brockmann I; Fischer M; Müller KM
    Pathol Res Pract; 1990 Apr; 186(2):238-46. PubMed ID: 1692994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
    Duggan MA; Masters CB; Alexander F
    Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistological coexpression of keratin and vimentin in the epithelial neoplastic cells].
    Lai RQ
    Zhonghua Bing Li Xue Za Zhi; 1990 Jun; 19(2):119-21. PubMed ID: 1697223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma.
    Flint A; Weiss SW
    Hum Pathol; 1995 Apr; 26(4):428-31. PubMed ID: 7535740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study.
    Said JW; Nash G; Banks-Schlegel S; Sassoon AF; Shintaku IP
    Hum Pathol; 1984 May; 15(5):440-3. PubMed ID: 6202620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmin and neural marker expression in mesothelial cells and mesotheliomas.
    Hurlimann J
    Hum Pathol; 1994 Aug; 25(8):753-7. PubMed ID: 7520015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.